Joel Greenblatt fit · Magic Formula - ROIC alto + EV/EBIT barato
Is Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) a Joel Greenblatt Stock?
Low Magic Formula score — expensive, low ROIC, or both.
7/100
FNão encaixa
3/5 critérios atendidos
Os critérios de Joel Greenblatt, aplicados a TAK
EBIT/EV yield ≥ 10%
chave10.7%
ROIC ≥ 25%
chave1.7%
EV/EBIT ≤ 12
9.3x
Gross margin ≥ 30%
55.6%
Como TAK pontua em outras estratégias
Dados financeiros ao vivo
Cap. de mercado
$51.34B
P/L (TTM)
43.0x
ROIC (TTM)
2.59%
Margem bruta
58.76%
Outras análises Joel Greenblatt
Perguntas frequentes
What is TAK's Joel Greenblatt fit score?
TAK scores 7/100 on our Joel Greenblatt fit engine — grade F. Low Magic Formula score — expensive, low ROIC, or both.
Does Joel Greenblatt actually own TAK?
Our score is computed from financial fundamentals against Joel Greenblatt's published criteria. We don't claim that Joel Greenblatt personally owns or recommends TAK.
How often is this score updated?
TAK's Joel Greenblatt fit score is recomputed daily from the latest TTM financials.
Ferramenta educacional, não é consultoria de investimento. As pontuações são calculadas a partir de dados financeiros públicos contra os critérios publicados de cada estratégia de investimento. Não afirmamos que Joel Greenblatt possua ou recomende TAK pessoalmente.